Journal of Thyroid Disorders & Therapy
Open Access
ISSN: 2167-7948
+44 1300 500008
ISSN: 2167-7948
+44 1300 500008
Department of Pharmacological, Stanford University, California, United States of America
Dr. William Thore is a renowned pharmacologist and professor in the Department of Pharmacology at Stanford University, California, USA. With expertise in drug development, molecular pharmacology, and therapeutic innovation, Dr. Thore has made significant contributions to the fields of neuropharmacology and oncology. His research focuses on understanding the molecular and cellular mechanisms of drug action, with an emphasis on developing targeted therapies for neurological disorders and cancer. Dr. Thore completed his medical degree and doctoral studies in pharmacology at leading institutions before pursuing postdoctoral research in neuropharmacology. His early research focused on the neurochemical pathways involved in neurodegenerative diseases such as Alzheimer's and Parkinson's disease, and more recently, he has extended his work to include drug discovery for cancer treatment, particularly targeting molecular drivers of tumor growth and metastasis. As an educator, Dr. Thore is deeply committed to fostering the next generation of pharmacologists and clinicians. At Stanford University, he has developed innovative teaching programs that integrate basic pharmacology with cutting-edge research on drug action and disease treatment. His mentorship has influenced many students, fellows, and young professionals who have gone on to lead successful careers in both academia and the pharmaceutical industry.
Perspective
The Significance of Goiter and the Determination of the Factors involved in its Development
Author(s): William Thore*
DOI:
10.35841/2167-7948.23.12.309